Skip to main content

INVO Fertility, Inc.

IVF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001417926

No open-market purchases or sales by INVO Fertility, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $248.7K in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding INVO Fertility, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of IVF: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders21119−1
Shares1.32M14.1K1.31M+2.94K (+0.2%)
Value$1.40M$15.0K$564.3K−$823.7K (−59.3%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held INVO Fertility, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to IVF in Q4 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC48,664$21.2K0.00%
HighTower Advisors, LLC22,047$9.00K0.00%
Jane Street Group, LLC17,790$7.54K0.00%
Bank of America Corp24$100.00%

Sold out (5)

Institutions that held INVO Fertility, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of IVF in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Bank of New York Mellon Corp50,000$53.0K
Connors Investor Services Inc49,000$52.0K
Group One Trading, L.P.1,600$2.00K
FMR LLC196$0
Simplex Trading, LLC76$0

Not filed for Q4 2022 yet (1)

Institutions that held INVO Fertility, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IVF in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Eidelman Virant Capital14,062$15.0K